Dendrimers for Drug Delivery
AbstractDendrimers have come a long way in the last 25 years since their inception. Originally created as a wonder molecule of chemistry, dendrimer is now in the fourth class of polymers. Dr. Donald Tomalia first published his seminal work on Poly(amidoamine) (PAMAM) dendrimers in 1985. Application of dendrimers as a drug delivery system started in late 1990s. Dendrimers for drug delivery are employed using two approaches: (i) formulation and (ii) nanoconstruct. In the formulation approach, drugs are physically entrapped in a dendrimer using non-covalent interactions, whereas drugs are covalently coupled on dendrimers in the nanoconstruct approach. We have demonstrated the utility of PAMAM dendrimers for enhancing solubility, stability and oral bioavailability of various drugs. Drug entrapment and drug release from dendrimers can be controlled by modifying dendrimer surfaces and generations. PAMAM dendrimers are also shown to increase transdermal permeation and specific drug targeting. Dendrimer platforms can be engineered to attach targeting ligands and imaging molecules to create a nanodevice. Dendrimer nanotechnology, due to its multifunctional ability, has the potential to create next generation nanodevices. View Full-Text
Share & Cite This Article
Chauhan, A.S. Dendrimers for Drug Delivery. Molecules 2018, 23, 938.
Chauhan AS. Dendrimers for Drug Delivery. Molecules. 2018; 23(4):938.Chicago/Turabian Style
Chauhan, Abhay S. 2018. "Dendrimers for Drug Delivery." Molecules 23, no. 4: 938.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.